CSF1R and Miyoshi myopathy: Notably, it was determined that CSF1R blockers bound to the chemotherapeutic agents bortezomib or meflanga remarkably decrease tumor load and increase the overall survival in mice with MM tumors, compared to those treated with monotherapy alone.32